| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7918823 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8920377 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US9056170 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US9833573 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8313466 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US10737028 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US9737669 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8361029 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8425462 | KALEO INC | Devices, systems, and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US8608698 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US10314977 | KALEO INC | Devices, systems and methods for medicament delivery |
Nov, 2024
(6 months from now) | |
| US7731690 | KALEO INC | Devices, systems and methods for medicament delivery |
Jan, 2025
(8 months from now) | |
| US8016788 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2025
(10 months from now) | |
| US10335549 | KALEO INC | Devices, systems and methods for medicament delivery |
Apr, 2025
(11 months from now) | |
| US9149579 | KALEO INC | Devices, systems and methods for medicament delivery |
Jul, 2025
(1 year, 2 months from now) | |
| US9278182 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2026
(1 year, 8 months from now) | |
| US9259539 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2026
(1 year, 8 months from now) | |
| US8926594 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2026
(1 year, 10 months from now) | |
| US7731686 | KALEO INC | Devices, systems and methods for medicament delivery |
Jun, 2026
(2 years from now) | |
| US10960155 | KALEO INC | Devices, systems and methods for medicament delivery |
Jun, 2026
(2 years from now) | |
| US11590286 | KALEO INC | Devices, systems and methods for medicament delivery |
Dec, 2026
(2 years from now) | |
| US9238108 | KALEO INC | Medicament delivery device having an electronic circuit system |
Feb, 2027
(2 years from now) | |
| US8206360 | KALEO INC | Devices, systems and methods for medicament delivery |
Feb, 2027
(2 years from now) | |
| US9724471 | KALEO INC | Devices, systems, and methods for medicament delivery |
May, 2027
(3 years from now) | |
| US7947017 | KALEO INC | Devices, systems and methods for medicament delivery |
Mar, 2028
(3 years from now) | |
| US7749194 | KALEO INC | Devices, systems, and methods for medicament delivery |
Oct, 2028
(4 years from now) | |
| US8231573 | KALEO INC | Medicament delivery device having an electronic circuit system |
Nov, 2028
(4 years from now) | |
| US8226610 | KALEO INC | Medical injector with compliance tracking and monitoring |
Apr, 2029
(4 years from now) | |
| US8021344 | KALEO INC | Medicament delivery device configured to produce an audible output |
Nov, 2029
(5 years from now) | |
| US10842938 | KALEO INC | Medicament delivery device and methods for delivering drugs to infants and children |
Dec, 2037
(13 years from now) | |
| US10688244 | KALEO INC | Medicament delivery device and methods for delivering drugs to infants and children |
Dec, 2037
(13 years from now) | |
| US11771830 | KALEO INC | Medicament delivery device and methods for delivering drugs to infants and children |
Dec, 2037
(13 years from now) | |
Auvi-Q is owned by Kaleo Inc.
Auvi-Q contains Epinephrine.
Auvi-Q has a total of 32 drug patents out of which 0 drug patents have expired.
Auvi-Q was authorised for market use on 17 November, 2017.
Auvi-Q is available in solution;intramuscular, subcutaneous dosage forms.
Auvi-Q can be used as method of treating an allergic reaction using an auto-injector, method for confirming dose delivery, method to treat severe allergic emergencies in patients weighing 7.5 to 15 kg (16.5 to 33 lbs), method of treating allergic reaction via injection.
The generics of Auvi-Q are possible to be released after 21 December, 2037.
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 17 November, 2017
Treatment: Method to treat severe allergic emergencies in patients weighing 7.5 to 15 kg (16.5 to 33 lbs); Method of treating allergic reaction via injection; Method for confirming dose delivery; Method of treat...
Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS
AUVI-Q family patents
